Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 26;9(6):141.
doi: 10.3390/biology9060141.

Lessons from SARS-CoV-2 Pandemic: Evolution, Disease Dynamics and Future

Saurabh Pandey  1 , Bharat Yadav  2 , Arvind Pandey  3 , Takshashila Tripathi  4 , Masuma Khawary  2 , Sashi Kant  5 , Deeksha Tripathi  2
Affiliations
Review

Lessons from SARS-CoV-2 Pandemic: Evolution, Disease Dynamics and Future

Saurabh Pandey et al. Biology (Basel). .

Abstract

The COVID-19 pandemic is rising at an unprecedented rate. The surging number of deaths every day, global lockdown and travel restrictions have resulted in huge losses to society. The impact is massive and will leave a historical footprint. The Spanish Flu of 1918, which was the last pandemic that had a similar impact, was shadowed under the consequences of World War I. All the brilliance, strength and economies of countries worldwide are aimed at fighting the COVID-19 pandemic. The knowledge about coronavirus dynamics, its nature and epidemiology are expanding every day. The present review aims to summarize the structure, epidemiology, symptoms, statistical status of the disease status, intervention strategies and deliberates the lessons learnt during the pandemic. The intervention approaches, antiviral drug repurposing and vaccine trials are intensified now. Statistical interpretations of disease dynamics and their projections may help the decision-makers.

Keywords: COVID-19; SARS-CoV-2; pandemic.

PubMed Disclaimer

Conflict of interest statement

Authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) Percentage distribution of number of deaths, recovery and active cases in worst-hit countries in the world. (B) Infection growth rate of some of the worst infected countries is shown. The data represent quite a linear growth.
Figure 2
Figure 2
Ten vaccine candidates are in clinical trial, as shown in the figure. Information was accessed and adapted from DRAFT landscape of COVID-19 candidate vaccines—prepared by WHO, accessed on 27 May 2020 [52].
Figure 3
Figure 3
The timeline represents the important events during the novel coronavirus born pandemic till June 2020.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
    1. Velavan T.P., Meyer C.G. The COVID-19 epidemic. Trop. Med. Int. Heal. 2020;25:278–280. doi: 10.1111/tmi.13383. - DOI - PMC - PubMed
    1. Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565–574. doi: 10.1016/S0140-6736(20)30251-8. - DOI - PMC - PubMed
    1. Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W., Tian J.-H., Pei Y.-Y., et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–269. doi: 10.1038/s41586-020-2008-3. - DOI - PMC - PubMed
    1. Helmy Y.A., Fawzy M., Elaswad A., Sobieh A., Kenney S.P., Shehata A.A. The COVID-19 pandemic: A comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. J. Clin. Med. 2020;9:1225. doi: 10.3390/jcm9041225. - DOI - PMC - PubMed

LinkOut - more resources